glucagon has been researched along with Metabolic Syndrome in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (33.33) | 29.6817 |
| 2010's | 10 (37.04) | 24.3611 |
| 2020's | 8 (29.63) | 2.80 |
| Authors | Studies |
|---|---|
| Fridh, MK; Gerbek, T; Hartmann, B; Holst, JJ; Mathiesen, S; Müller, K; Nissen, AA; Soerum, ME; Sørensen, K; Vadmand, AC | 1 |
| Aravindhan, V; Babu, S; Deepa, M; Mohan, V; Sibi, JM | 1 |
| Cortes-Justo, E; Garfias-Ramírez, SH; Vilches-Flores, A | 1 |
| Chaves, IZ; Hansen, KE; Murali, S; Ney, DM; Suen, G | 1 |
| Golovina, EL; Grishkevich, IR; Kudlay, DA; Matveeva, MV; Podchinenova, DV; Samoilova, IG; Vaizova, OE | 1 |
| Andrés, A; de Solís, AJ; Fernández, A; Gallardo, N; López, V; Mazuecos, L; Pintado, C; Rodríguez, M; Rubio, B | 1 |
| Cardone, RL; Cravatt, BF; Gillum, MP; Grevengoed, TJ; Kibbey, RG; Knop, FK; McKinney, MK; Nexøe-Larsen, CC; Ogasawara, D; Petersen, N; Schwartz, TW; Svenningsen, JS; Trammell, SAJ | 1 |
| Azhar, S; Bittner, A; Bittner, S; Chan, J; Cortez, Y; Dong, D; Han, L; Kraemer, FB; Peterson, RG; Shen, WJ; Umar, M | 1 |
| Bao, S; Chen, D; Hu, L; Jiang, H; Li, J; Liu, J; Liu, W; Sun, S; Wang, X; Xie, Z; Zhang, X; Zhang, Y; Zhou, C | 1 |
| Alimogullari, E; Bilginoglu, A; Cayli, S; Nakkas, H; Piskin, I | 1 |
| Bowden, DW; Cox, AJ; Cripps, AW; Davoren, PM; Devereaux, B; West, NP; Zhang, P | 1 |
| Haluzík, M; Holubová, M; Hrubá, L; Kuneš, J; Maletínská, L; Mikulášková, B; Pražienková, V; Železná, B; Zemenová, J | 1 |
| Eckel, RH; Koh, KK; Lim, S | 1 |
| Bano, G | 1 |
| Beglinger, C; Beglinger, S; Drewe, J; Graf, S; Gutzwiller, JP; Meyer-Gerspach, AC; Zumsteg, U | 1 |
| Carreras, O; Díaz-Castro, J; Muñoz Del Valle, P; Murillo, ML; Nogales, F; Ojeda, ML | 1 |
| Dasilva, G; Medina, I; Molinar-Toribio, E; Pérez-Jiménez, J; Ramos-Romero, S; Romeu, M; Taltavull, N; Torres, JL | 1 |
| Angelin, B; Bonde, Y | 1 |
| Debaty, I; Halimi, S; Muller, M; Villaret, L | 1 |
| Ernsberger, P; Koletsky, RJ; Velliquette, RA | 2 |
| Roden, M; Stingl, H | 1 |
| Rosa, J; Skala, H | 1 |
| Baptista, T; Beaulieu, S; Contreras, Q; de Mendoza, S; Galeazzi, T; Lacruz, A; Rangel, N; Sandia, I; Vargas, D | 1 |
| Herzig, S | 1 |
| Li, XC; Zhuo, JL | 1 |
| Chen, S; Grayburn, P; Orci, L; Ravazzola, M; Unger, RH; Wang, MY | 1 |
6 review(s) available for glucagon and Metabolic Syndrome
| Article | Year |
|---|---|
[Genetic aspects of type 1 glucagon peptide agonists clinical efficacy: A review].
Topics: Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Metabolic Syndrome; Peptides; Venoms | 2023 |
Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors.
Topics: Albuminuria; Atherosclerosis; Benzhydryl Compounds; Body Weight; Canagliflozin; Cardiovascular Diseases; Cardiovascular System; Glucagon; Glucagon-Like Peptides; Glucosides; Heart Failure; Hemodynamics; Humans; Hypoglycemic Agents; Ketones; Lipids; Liraglutide; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Osmosis; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2018 |
[New therapies for type 2 diabetes: what place for incretin-based agents and rimonabant compared to the previous ones?].
Topics: Administration, Oral; Diabetes Mellitus, Type 2; Glucagon; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Metabolic Syndrome; Metformin; Piperidines; Pyrazoles; Rimonabant; Safety; Sulfonylurea Compounds; Thiazolidinediones | 2008 |
[Future targets in the treatment of type 2 diabetes].
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Forecasting; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycated Hemoglobin; Glycogen Synthase Kinase 3; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Lipid Peroxidation; Metabolic Syndrome; Mice; Oxazines; Peptide Fragments; Phenylpropionates; Protein Precursors; Rats; Receptor, Insulin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors | 2004 |
[Transcription factors and metabolic diseases].
Topics: Cholesterol; Genetic Predisposition to Disease; Glucagon; Gluconeogenesis; Humans; Liver; Metabolic Syndrome; Transcription Factors | 2007 |
Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucagon; Humans; Hypoglycemic Agents; Metabolic Syndrome; Receptors, Glucagon; Signal Transduction | 2007 |
2 trial(s) available for glucagon and Metabolic Syndrome
| Article | Year |
|---|---|
Effect of a test meal on meal responses of satiation hormones and their association to insulin resistance in obese adolescents.
Topics: Adolescent; Body Mass Index; Child; Female; Gastrointestinal Hormones; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Male; Meals; Metabolic Syndrome; Pediatric Obesity; Postprandial Period; Satiation | 2014 |
Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; C-Reactive Protein; Double-Blind Method; Female; Fibrinogen; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Metformin; Middle Aged; Olanzapine; Schizophrenia; Sex Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
19 other study(ies) available for glucagon and Metabolic Syndrome
| Article | Year |
|---|---|
Metabolic Dysregulation in Adult Survivors of Pediatric Hematopoietic Stem Cell Transplantation: The Role of Incretins.
Topics: Adult; Blood Glucose; Child; Cross-Sectional Studies; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Hematopoietic Stem Cell Transplantation; Humans; Incretins; Insulin; Male; Metabolic Syndrome; Survivors | 2023 |
Modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome (DM-LF5).
Topics: Child; Glucagon; Humans; Insulin; Metabolic Syndrome | 2022 |
The function of the endocannabinoid system in the pancreatic islet and its implications on metabolic syndrome and diabetes.
Topics: Animals; Diabetes Mellitus; Endocannabinoids; Glucagon; Humans; Insulin; Islets of Langerhans; Metabolic Syndrome; Receptors, Cannabinoid | 2023 |
Glycomacropeptide Impacts Amylin-Mediated Satiety, Postprandial Markers of Glucose Homeostasis, and the Fecal Microbiome in Obese Postmenopausal Women.
Topics: Blood Glucose; Cross-Over Studies; Female; Glucagon; Glucose; Homeostasis; Humans; Insulin; Islet Amyloid Polypeptide; Metabolic Syndrome; Obesity; Postmenopause; Postprandial Period | 2023 |
Effects of Moderate Chronic Food Restriction on the Development of Postprandial Dyslipidemia with Ageing.
Topics: Adiposity; Aging; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blood Glucose; Diet, Fat-Restricted; Dietary Fats; Disease Models, Animal; Dyslipidemias; Glucagon; Insulin; Lipids; Liver; Metabolic Syndrome; Postprandial Period; Rats; Rats, Wistar; Triglycerides | 2019 |
Topics: Amidohydrolases; Amino Acid Substitution; Animals; Blood Glucose; Disease Models, Animal; Eating; Ethanolamines; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Islets of Langerhans; Male; Metabolic Syndrome; Mice; Mice, Transgenic; Middle Aged; Oleic Acids; Postprandial Period; Receptors, G-Protein-Coupled; Taurine | 2019 |
Molecular changes in hepatic metabolism in ZDSD rats-A new polygenic rodent model of obesity, metabolic syndrome, and diabetes.
Topics: Amino Acids; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Humans; Hypertension; Insulin; Lipid Metabolism; Liver; Male; Metabolic Syndrome; Multifactorial Inheritance; Obesity; Pancreas; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Rats, Zucker | 2020 |
The triterpenoid sapogenin (2α-OH-Protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR/GLP-1 axis through gut microbiota remodelling.
Topics: Animals; Diet, High-Fat; Drug Design; Gastrointestinal Microbiome; Glucagon; Glucagon-Like Peptide 1; Gynostemma; Intestines; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Plant Extracts; RNA-Binding Proteins; RNA, Ribosomal, 16S; Taurocholic Acid | 2020 |
Effect of pioglitazone on the expression of ubiquitin proteasome system and autophagic proteins in rat pancreas with metabolic syndrome.
Topics: Animals; Apoptosis; Autophagy; Autophagy-Related Proteins; Cell Proliferation; Glucagon; Insulin; Male; Metabolic Syndrome; Microtubule-Associated Proteins; Pancreas; Pioglitazone; Proteasome Endopeptidase Complex; Rats, Wistar; Ubiquitin | 2021 |
Enteroendocrine and adipokine associations with type 2 diabetes: Phenotypic risk scoring approaches.
Topics: Adipokines; Adolescent; Adult; Aged; Body Mass Index; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Metabolic Syndrome; Middle Aged; Phenotype; Risk Assessment; Young Adult | 2018 |
Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
Topics: Adipose Tissue; Animals; Blood Glucose; Blood Pressure; Body Weight; Brain; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Hypertension; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Obesity; Prolactin-Releasing Hormone; Rats, Inbred SHR | 2018 |
Glucose homeostasis, obesity and diabetes.
Topics: Aging; Body Mass Index; Diabetes Mellitus, Type 2; Glucagon; Glucose; Glucose Intolerance; Glucose Transport Proteins, Facilitative; Glycogen; Homeostasis; Humans; Inflammation Mediators; Insulin; Insulin Resistance; Metabolic Syndrome; Obesity; Obesity, Abdominal; Sodium-Glucose Transport Proteins | 2013 |
Metabolic syndrome and selenium in fetal programming: gender differences.
Topics: Animals; Animals, Newborn; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Female; Fetal Development; Fructose; Gastric Inhibitory Polypeptide; Glucagon; Glutathione Peroxidase; Homeostasis; Insulin; Leptin; Liver; Male; Metabolic Syndrome; Osteopontin; Oxidative Stress; RANK Ligand; Rats; Rats, Wistar; Selenium; Sex Factors; Triglycerides; Triiodothyronine | 2016 |
The combined action of omega-3 polyunsaturated fatty acids and grape proanthocyanidins on a rat model of diet-induced metabolic alterations.
Topics: Adiponectin; Adiposity; Animals; Blood Glucose; Body Weight; Cholesterol; Diet; Dietary Supplements; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Ghrelin; Glucagon; Insulin; Leptin; Metabolic Syndrome; Proanthocyanidins; Rats; Rats, Inbred WKY; Triglycerides; Vitis | 2016 |
Metabolic Syndrome: One Speckled Stone Kills a Flock of Birds?
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fatty Liver; Glucagon; Hormones; Humans; Metabolic Syndrome; Triiodothyronine | 2017 |
The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Blood Pressure; Disease Models, Animal; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Imidazoles; Imidazoline Receptors; Lipid Metabolism; Male; Metabolic Syndrome; Obesity; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Yohimbine | 2003 |
Effects of vanadate on glucose production in cultured hepatocytes isolated from rats on high saturated fat diet.
Topics: Animals; Cells, Cultured; Dietary Fats; Glucagon; Glucose; Hepatocytes; Insulin; Male; Metabolic Syndrome; Rats; Rats, Wistar; Vanadates | 2005 |
Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Animals; Calcium-Binding Proteins; Cardiomyopathies; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Glucagon; Insulin; Intercellular Signaling Peptides and Proteins; Metabolic Syndrome; Mice; Mice, Transgenic; Obesity; Pancreas; Promoter Regions, Genetic; Receptors, Leptin; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Transgenes | 2008 |
Plasma glucagon and free fatty acid responses to a glucose load in the obese spontaneous hypertensive rat (SHROB) model of metabolic syndrome X.
Topics: Animals; Fatty Acids; Glucagon; Glucose; Glucose Tolerance Test; Metabolic Syndrome; Obesity; Rats; Rats, Inbred SHR | 2002 |